NEW YORK (GenomeWeb) – Hologic reported after the close of the market on Wednesday that its second quarter revenues rose 3 percent, driven in part by solid growth in molecular diagnostics.

For the three months ended March 31, the firm reported revenues of $715.4 million, up from $693.3 million a year ago, and beating the consensus Wall Street estimate of $685.4 million.